Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Exercise & healthspan
Research brief

Wearable step-count processing pipeline tested in older STRRIDE-PD Reunion participants

A described, reproducible procedure turned Garmin step-count data from 67 older adults into daily summaries; wearable steps were linked to 9 of 16 cardiometabolic and fitness outcomes, while self-reported exercise was linked to none. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The described procedure converts epoch-level Garmin step counts into participant-level variables using a prespecified valid-day threshold of at least 10 hours of inferred wear time. [1]

  2. Among 67 participants, median valid days were 10 and median average daily steps were 5794. [1]

  3. Wearable step counts were significantly associated with 9 of 16 outcomes, while self-reported exercise was not significantly associated with any. [1]

The source at a glance

Study type / format
Methods description with application in a long-term follow-up cohort study (abstract).
Population / context
67 older adults (mean age 71.4 years, 65.7% women) in the STRRIDE-PD Reunion follow-up.
Summary based on
Study abstract
Original publication
September 24, 2026

Pipeline for Garmin steps in 67 older adults

The authors describe a transparent, reproducible standard operating procedure for turning epoch-level step counts from commercial Garmin devices into participant-level variables. It standardizes timestamps, rebuilds daily epoch grids, infers wear time from observed step patterns and applies a prespecified valid-day threshold of at least 10 hours of inferred wear time. They applied it in the STRRIDE-PD Reunion study, a long-term follow-up of older adults originally enrolled in a supervised exercise intervention trial.

Supporting source [1]

Median 10 valid days and 5794 daily steps

Among 67 participants (mean age 71.4 years, 65.7% women), the median number of valid days was 10 and median average daily steps were 5794. Participant-level estimates were identical whether the valid-day threshold was at least 10 hours or at least 6 hours.

Supporting source [1]

Wearable steps linked to 9 of 16 outcomes

Wearable-derived step counts were significantly associated with 9 of 16 cardiometabolic and fitness outcomes, including cardiorespiratory fitness, body composition and lipid profiles. Self-reported exercise, a frequency-by-duration composite ranked into deciles, was not significantly associated with any outcome. Regression calibration suggested measurement limitations in self-reported exercise may have contributed to weaker associations than with Garmin-derived and calibration-corrected estimates. These are associations, not evidence of cause.

Supporting source [1]

How to interpret this

Abstract only; the full text was not reviewed. The authors note a modest analytic sample size, possible violations of measurement error assumptions, relatively brief monitoring and indirect wear-time inference. Associations do not show causation.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

[1]
A reproducible pipeline for processing commercial wearable step-count data in aging cohorts: Application and evaluation in the STRRIDE-PD reunion study.

Bo N, Sudnick AM, Counts JD, Kennedy KG, Saldana AA, Collins-Bennett KA, Bennett WC, Johnson JL, Huffman KM, Paluch AE, Ashner MC, Kraus WE, Peskoe SB, Ross LM. · europepmc.org · September 24, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    a prespecified valid-day threshold (≥10 h inferred
  2. Finding 2 ↑

    the median valid-day count was 10 days
  3. Finding 3 ↑

    significantly associated with 9 of 16 cardiometabolic

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…